Doripenem: a review of its use in the treatment of bacterial infections.
about
CarbapenemsEvolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients.Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria.Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility.Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections.ESBLs: A Clear and Present Danger?Evaluation of doripenem utilization and susceptibilities at a large urban hospital.Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studiesCharacteristics of doripenem: a new broad-spectrum antibiotic.Antimicrobial activity of doripenem against bacterial isolates from humans and animals.Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator.Clinical efficacy of i.v. doripenem, a new class of carbapenem, in patients with biliary tract infection: A multicenter trial.Evaluation of the double-disk synergy test for New Delhi metallo-β-lactamase-1 and other metallo-β-lactamase producing gram-negative bacteria by using metal-ethylenediaminetetraacetic acid complexes.Determination of doripenem penetration into human prostate tissue and assessment of dosing regimens for prostatitis based on site-specific pharmacokinetic-pharmacodynamic evaluation.
P2860
Q28286055-61258941-F74B-48FB-B930-707F4F24E6C5Q28752557-410D5C83-998D-4C81-AF2A-B0A0D7A9D16CQ33553063-70B1AFBA-096D-45FC-8F5F-79F430303AAFQ34140513-7AE89689-1F73-4359-B0DD-48B449ACFC29Q34433108-9DA2E540-3090-4A20-8E59-CF3AFC346CD5Q35026526-DEBAD77A-1941-4EB5-ABE6-6E4B4CA365B0Q35101453-C0CDD609-C80A-48C8-B060-B3000A08429FQ40002163-706BD5E4-2264-4138-BC63-46139D053478Q40337526-2F38F00E-F598-4B91-AB30-F3AA0A2CD4DBQ42049594-0ACA0BF1-54AD-409B-B021-CF99C52D1A99Q42934573-2E3E5350-B214-476B-8993-BD77228C4244Q44001871-DCE0B0BB-D935-4643-9173-4AD8E6BB9664Q50178436-13D41820-7F8E-41BD-8C7D-DC3DA308CA8FQ54311391-8AF4D6FA-6F5F-49FB-9BB6-DBE0F51D95BFQ54337445-EB14036E-4C25-4E5B-BA11-E85D83D1FE06
P2860
Doripenem: a review of its use in the treatment of bacterial infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Doripenem: a review of its use in the treatment of bacterial infections.
@en
Doripenem: a review of its use in the treatment of bacterial infections.
@nl
type
label
Doripenem: a review of its use in the treatment of bacterial infections.
@en
Doripenem: a review of its use in the treatment of bacterial infections.
@nl
prefLabel
Doripenem: a review of its use in the treatment of bacterial infections.
@en
Doripenem: a review of its use in the treatment of bacterial infections.
@nl
P1433
P1476
Doripenem: a review of its use in the treatment of bacterial infections
@en
P2093
Susan J Keam
P2860
P304
P356
10.2165/00003495-200868140-00007
P50
P577
2008-01-01T00:00:00Z
P6179
1027449679